FDA Finds ‘Extremely High’ Lead Levels In Cinnamon Used In Tainted Fruit Pouches
The cinnamon, which originated from a plant in Ecuador, had lead levels more than 2,000 times higher than a maximum level proposed by the FDA, officials said.
Similar Posts
Want Better Skin? Using This 1 Thing Before Bed Can Help And It’s Already In Your Home
HuffPost’s “Am I Doing It Wrong” chatted with Dr. Sherwin Parikh to get the lowdown on a nighttime skincare routine that will get you glowing.
Covid inquiry postpones vaccine investigation
The probe into vaccines and Covid drugs planned for the summer of 2024 has been delayed, inquiry officials have said.
This Handheld Tool Can Make Your Disgusting Mattress A Little Cleaner
It’s accurate to assume that germs are lurking everywhere in your home, but your mattress is one particular place that harbors untold microorganisms that many of us prefer not to think about. In fact, mattresses are more disgusting than you might ever have imagined, according to Manal Mohammed, a medical microbiologist and senior lecturer at London’s University…
Mary Lou Retton Faces Long Recovery After Pneumonia Scare
Olympic gymnastics great Mary Lou Retton said she faces a long battle recuperating at home from a rare form of pneumonia in which doctors weren’t sure whether she would survive. In an interview that aired Monday on NBC’s “Today” show, Retton said while wearing a breathing tube pumping oxygen through her nose that she was…
Oprah’s flip on weight loss drugs is a sign of what’s to come for the ‘Ozempic trade’ in 2024
For many struggling with obesity, new medications have been “a gift,” as Oprah Winfrey recently described it in declaring she was “done with the shaming.” Investors in drug manufacturers Novo Nordisk and Eli Lilly might use the same term for the returns they’ve realized over the past year. U.S.-listed shares of Novo Nordisk, the maker…
Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal
Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share. Karuna’s stock closed up more than 47% on the news Friday, hitting $317.85 a share. Bristol Myers Squibb shares closed up 2%. The deal will help expand Bristol Myers’ drug pipeline after…
